İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2010 · article

Predictors of pregnancy complications in women with congenital heart disease

Dergi European Heart Journal
OpenAlex Açık erişim · bronze Üst %1
Yıl2010
Atıf704OpenAlex
Atıf625Semantic Scholar · 27 etkili
Yüzdelik%99,0
FWCI12,521,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİS dergi adıEuropean Heart Journal
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

AIMS: Data regarding pregnancy outcome in women with congenital heart disease (CHD) are limited. METHODS AND RESULTS: In 1802 women with CHD, 1302 completed pregnancies were observed. Independent predictors of cardiac, obstetric, and neonatal complications were calculated using logistic regression. The most prevalent cardiac complications during pregnancy were arrhythmias (4.7%) and heart failure (1.6%). Factors independently associated with maternal cardiac complications were the presence of cyanotic heart disease (corrected/uncorrected) (P < 0.0001), the use of cardiac medication before pregnancy (P < 0.0001), and left heart obstruction (P < 0.0001). New characteristics were mechanical valve replacement (P = 0.0014), and systemic (P = 0.04) or pulmonary atrioventricular valve regurgitation related with the underlying (moderately) complex CHD (P = 0.03). A new risk score for cardiac complications is proposed. The most prevalent obstetric complications were hypertensive complications (12.2%). No correlation of maternal characteristics with adverse obstetric outcome was found. The most prevalent neonatal complications were premature birth (12%), small for gestational age (14%), and mortality (4%). Cyanotic heart disease (corrected/uncorrected) (P = 0.0003), mechanical valve replacement (P = 0.03), maternal smoking (P = 0.007), multiple gestation (P = 0.0014), and the use of cardiac medication (P = 0.0009) correlated with adverse neonatal outcome. CONCLUSION: In our tertiary CHD cohort, cardiac, obstetric, and neonatal complications were frequently encountered, and (new) correlations of maternal baseline data with adverse outcome are reported. A new risk score for adverse cardiac complications is proposed, although prospective validation remains necessary.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

704atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 22 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2018 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancyAtıf 2.324 · OpenAlex
  2. 2014 Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart diseaseAtıf 262 · OpenAlex
  3. 2025 2025 ESC Guidelines for the management of cardiovascular disease and pregnancyAtıf 252 · OpenAlex
  4. 2013 N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart diseaseAtıf 123 · OpenAlex
  5. 2013 Uteroplacental Blood Flow, Cardiac Function, and Pregnancy Outcome in Women With Congenital Heart DiseaseAtıf 118 · OpenAlex
  6. 2016 Cardiac adaption during pregnancy in women with congenital heart disease and healthy womenAtıf 44 · OpenAlex
  7. 2011 Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II studyAtıf 38 · OpenAlex
  8. 2016 Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of FallotAtıf 32 · OpenAlex
  9. 2018 General Concepts in Adult Congenital Heart DiseaseAtıf 29 · OpenAlex
  10. 2014 Cardiac function and cardiac events 1-year postpartum in women with congenital heart diseaseAtıf 28 · OpenAlex

Yazarlar

Yazar bilgisi yok.